Kronos Bio, Inc. financial data

Location
San Mateo, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q1 2025 - 08 May 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 881% % 7%
Debt-to-equity 36% % 13%
Return On Equity -64% % 6.5%
Return On Assets -47% % 9.3%
Operating Margin -765% % 54%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 60,969,214 shares 1.5%
Common Stock, Shares, Outstanding 60,969,000 shares 1.5%
Entity Public Float $46,300,000 USD -4.1%
Common Stock, Value, Issued $61,000 USD 1.7%
Weighted Average Number of Shares Outstanding, Basic 60,807,000 shares 2.2%
Weighted Average Number of Shares Outstanding, Diluted 60,807,000 shares 2.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $9,192,000 USD 21%
Research and Development Expense $36,558,000 USD -54%
General and Administrative Expense $23,232,000 USD -36%
Operating Income (Loss) $70,335,000 USD 44%
Nonoperating Income (Expense) $5,850,000 USD -36%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $64,485,000 USD 45%
Earnings Per Share, Basic -1 USD/shares 46%
Earnings Per Share, Diluted -1 USD/shares 46%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $91,577,000 USD 98%
Assets, Current $101,873,000 USD -36%
Property, Plant and Equipment, Net $1,081,000 USD -87%
Operating Lease, Right-of-Use Asset $3,048,000 USD -78%
Other Assets, Noncurrent $112,000 USD -81%
Assets $108,140,000 USD -41%
Accounts Payable, Current $1,570,000 USD -29%
Employee-related Liabilities, Current $148,000 USD -85%
Accrued Liabilities, Current $7,617,000 USD -33%
Contract with Customer, Liability, Current $0 USD -100%
Liabilities, Current $7,879,000 USD -59%
Contract with Customer, Liability, Noncurrent $0 USD -100%
Operating Lease, Liability, Noncurrent $20,449,000 USD -16%
Liabilities $28,328,000 USD -38%
Accumulated Other Comprehensive Income (Loss), Net of Tax $0 USD
Retained Earnings (Accumulated Deficit) $603,304,000 USD -12%
Stockholders' Equity Attributable to Parent $79,812,000 USD -42%
Liabilities and Equity $108,140,000 USD -41%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $12,842,000 USD 46%
Net Cash Provided by (Used in) Financing Activities $0 USD
Net Cash Provided by (Used in) Investing Activities $19,848,000 USD 244%
Common Stock, Shares Authorized 200,000,000 shares 0%
Common Stock, Shares, Issued 60,969,000 shares 1.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $7,006,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $93,603,000 USD 94%
Deferred Tax Assets, Valuation Allowance $141,440,000 USD 15%
Deferred Tax Assets, Gross $141,631,000 USD 12%
Operating Lease, Liability $24,089,000 USD -12%
Depreciation $1,742,000 USD -20%
Payments to Acquire Property, Plant, and Equipment $0 USD -100%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $64,436,000 USD 44%
Lessee, Operating Lease, Liability, to be Paid $30,787,000 USD -16%
Property, Plant and Equipment, Gross $4,502,000 USD -72%
Operating Lease, Liability, Current $3,640,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,874,000 USD -9.8%
Lessee, Operating Lease, Liability, to be Paid, Year One $5,405,000 USD -8.7%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,698,000 USD -26%
Lessee, Operating Lease, Liability, to be Paid, Year Three $5,020,000 USD 3%
Deferred Tax Assets, Operating Loss Carryforwards $80,742,000 USD 18%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Unrecognized Tax Benefits $5,290,000 USD 21%
Lessee, Operating Lease, Liability, to be Paid, Year Four $5,171,000 USD 3%
Operating Lease, Payments $5,900,000 USD -3.3%
Additional Paid in Capital $683,055,000 USD 1.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization $220,000 USD -54%
Deferred Tax Assets, Net of Valuation Allowance $191,000 USD -95%
Share-based Payment Arrangement, Expense $7,035,000 USD -73%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%